Changes in Plasma Half-life and Clearance of 3H-25-hydroxyvitamin D3 in Patients with Intestinal Malabsorption

Overview

Journal Gut

Specialty Gastroenterology

Date 1982 Dec 1

PMID 7173717

Citations 13

Authors

A J Batchelor

G Watson

J E Compston

Affiliations

Soon will be listed here.

Abstract

The plasma disappearance of intravenously administered tracer doses of tritium-labelled 25-hydroxyvitamin D3 (25OHD3) wa studied in six normal subjects and in 15 patients with intestinal malabsorption. The plasma half-life was significantly shorter and the clearance rate significantly greater in the group with malabsorption compared with the controls. One explanation for this increased elimination could be interruption of an enterohepatic circulation of 25OHD occurring in subjects with malabsorption and such a mechanism could account for the loss of endogenous vitamin D in these patients.

Citing Articles

The Effect of a Gluten-Free Diet on Vitamin D Metabolism in Celiac Disease: The State of the Art.

Di Stefano M, Miceli E, Mengoli C, Corazza G, Di Sabatino A Metabolites. 2023; 13(1).

PMID: 36676999 PMC: 9861273. DOI: 10.3390/metabo13010074.

The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation....

Cianferotti L, Cricelli C, Kanis J, Nuti R, Reginster J, Ringe J Endocrine. 2015; 50(1):12-26.

PMID: 25931412 DOI: 10.1007/s12020-015-0606-x.

Regulation of calcitriol biosynthesis and activity: focus on gestational vitamin D deficiency and adverse pregnancy outcomes.

Olmos-Ortiz A, Avila E, Durand-Carbajal M, Diaz L Nutrients. 2015; 7(1):443-80.

PMID: 25584965 PMC: 4303849. DOI: 10.3390/nu7010443.

Predictors of 25(OH)D half-life and plasma 25(OH)D concentration in The Gambia and the UK.

Jones K, Assar S, Vanderschueren D, Bouillon R, Prentice A, Schoenmakers I Osteoporos Int. 2014; 26(3):1137-46.

PMID: 25278297 PMC: 4331602. DOI: 10.1007/s00198-014-2905-0.

Determination of optimal cholecalciferol treatment in renal transplant recipients using a population pharmacokinetic approach.

Benaboud S, Urien S, Thervet E, Prie D, Legendre C, Souberbielle J Eur J Clin Pharmacol. 2012; 69(3):499-506.

PMID: 22936122 DOI: 10.1007/s00228-012-1378-3.

References

Avioli L, Birge S, Lee S . Effects of prednisone on vitamin D metabolism in man. J Clin Endocrinol Metab. 1968; 28(9):1341-6. DOI: 10.1210/jcem-28-9-1341. View

Mawer E, Schaefer K, LUMB G, STANBURY S . The metabolism of isotopically labelled vitamin D3 in man: the influence of the state of vitamin D nutrition. Clin Sci. 1971; 40(1):39-53. DOI: 10.1042/cs0400039. View

KIMBERG D, BAERG R, Gershon E, Graudusius R . Effect of cortisone treatment on the active transport of calcium by the small intestine. J Clin Invest. 1971; 50(6):1309-21. PMC: 292062. DOI: 10.1172/JCI106610. View

Edelstein S, Charman M, LAWSON D, KODICEK E . Competitive protein-binding assay for 25-hydroxycholecalciferol. Clin Sci Mol Med. 1974; 46(2):231-40. DOI: 10.1042/cs0460231. View

Gray R, Weber H, Dominguez J, LEMANN Jr J . The metabolism of vitamin D3 and 25-hydroxyvitamin D3 in normal and anephric humans. J Clin Endocrinol Metab. 1974; 39(6):1045-56. DOI: 10.1210/jcem-39-6-1045. View

Arnaud S, GOLDSMITH R, Lambert P, Go V . 25-Hydroxyvitamin D3: evidence of an enterohepatic circulation in man. Proc Soc Exp Biol Med. 1975; 149(2):570-2. DOI: 10.3181/00379727-149-38853. View

Lukert B, Adams J . Vitamin D metabolism in man. Effect of corticosteroids. Arch Intern Med. 1976; 136(11):1241-8. View

Teitelbaum S, Halverson J, Bates M, Wise L, Haddad J . Abnormalities of circulating 25-OH vitamin D after jejunal-lleal bypass for obesity: evidence of an adaptive response. Ann Intern Med. 1977; 86(3):289-93. DOI: 10.7326/0003-4819-86-3-289. View

Compston J, Creamer B . Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection. Gut. 1977; 18(3):171-5. PMC: 1411385. DOI: 10.1136/gut.18.3.171. View

10.

Klein R, Arnaud S, Gallagher J, DeLuca H, Riggs B . Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose. J Clin Invest. 1977; 60(1):253-9. PMC: 372363. DOI: 10.1172/JCI108762. View

11.

Hahn T, Halstead L, Haddad Jr J . Serum 25-hydroxyvitamin D concentrations in patients receiving chronic corticosteroid therapy. J Lab Clin Med. 1977; 90(2):399-404. View

12.

Schoen M, Lindenbaum J, ROGINSKY M, Holt P . Significance of serum level of 25-hydroxycholecalciferol in gastrointestinal disease. Am J Dig Dis. 1978; 23(2):137-42. DOI: 10.1007/BF01073189. View

13.

Compston J, Horton L, Laker M, Ayers A, Woodhead J, BULL H . Bone disease after jejuno-ileal bypass for obesity. Lancet. 1978; 2(8079):1-4. DOI: 10.1016/s0140-6736(78)91318-1. View

14.

Compston J, Merrett A, Hammett F, Magill P . Comparison of the appearance of radiolabelled vitamin D3 and 25-hydroxy-vitamin D3 in the chylomicron fraction of plasma after oral administration in man. Clin Sci (Lond). 1981; 60(2):241-3. DOI: 10.1042/cs0600241. View

15.

Compston J, Merrett A, Ledger J, Creamer B . Faecal tritium excretion after intravenous administration of 3H-25-hydroxyvitamin D3 in control subjects and in patients with malabsorption. Gut. 1982; 23(4):310-5. PMC: 1419735. DOI: 10.1136/gut.23.4.310. View

16.

Haddad Jr J, Hahn T . Natural and synthetic sources of circulating 25-hydroxyvitamin D in man. Nature. 1973; 244(5417):515-7. DOI: 10.1038/244515a0. View